Celgene Corp (CELG)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2003 | 12-2002 | 12-2001 | 12-2000 | 12-1999 | |
| Sales | 271,475 | 135,746 | 114,243 | 84,908 | 38,192 |
| Cost of Goods | 52,950 | 20,867 | 13,571 | 9,987 | 3,217 |
| Gross Profit | 218,525 | 114,879 | 100,672 | 74,921 | 34,975 |
| Operating Expenses | 222,124 | 230,367 | 126,186 | 110,217 | 65,857 |
| Operating Income | -2,649 | -114,621 | -24,943 | -34,309 | -30,665 |
| Interest Expense | 5,667 | 27 | 83 | 2,081 | 3,291 |
| Other Income | 33,977 | 23,058 | 20,890 | 17,577 | 1,302 |
| Pre-tax Income | 25,661 | -91,590 | -4,136 | -18,813 | -32,655 |
| Income Tax | 718 | -98 | -1,232 | -1,810 | -3,018 |
| Net Income Continuous | 24,943 | -91,492 | -2,904 | -17,004 | -29,637 |
| Net Income Discontinuous | 750 | 1,000 | 992 | 719 | N/A |
| Net Income | $25,693 | $-90,492 | $-1,912 | $-16,284 | $-29,637 |
| EPS Basic Total Ops | 0.04 | -0.15 | 0.00 | -0.03 | -0.07 |
| EPS Basic Continuous Ops | 0.04 | -0.15 | -0.01 | -0.03 | -0.07 |
| EPS Basic Discontinuous Ops | 0.01 | 0.00 | 0.00 | 0.00 | N/A |
| EPS Diluted Total Ops | 0.04 | -0.15 | 0.00 | -0.03 | -0.07 |
| EPS Diluted Continuous Ops | 0.04 | -0.15 | -0.01 | -0.03 | -0.07 |
| EPS Diluted Discontinuous Ops | 0.01 | 0.00 | 0.00 | 0.00 | N/A |
| EBITDA(a) | $8,175 | $-109,072 | $-19,617 | $-29,612 | $-27,184 |